Literature DB >> 15344598

Global expression analysis of the fibroblast transcriptional response to TGFbeta.

H Gardner1, D Strehlow, L Bradley, R Widom, A Farina, A de Fougerolles, J Peyman, V Koteliansky, J H Korn.   

Abstract

OBJECTIVES: Transforming Growth Factor-beta (TGFbeta) is the predominant cytokine in all forms of fibrotic reactions. As well as being secreted by immune modulators of fibrosis such as macrophages, it is involved in an autocrine feedback loop of fibroblast stimulation whose regulation is still poorly understood. We wished to gain some insight into the mechanisms of the fibroblast response to TGFbeta.
METHODS: We undertook an exhaustive transcript profiling experiment using a widely validated restriction enzyme based method for identifying differentially expressed genes (GeneCalling). Transcriptional responses throughout a 24-hour time course were examined at multiple time points and classified.
RESULTS: By 24 hours of TGF treatment over 1000 bands, representing a large number of transcripts, were down- or upregulated greater than 2-fold. All of the known genes responsive to TGFbeta, such as collagen and connective tissue growth factor, were upregulated.
CONCLUSIONS: This encyclopedic method revealed many unknown transcriptional responses to TGFbeta including the upregulation of a variety of less expected cytoskeletal and matrix components, as well as interactions between the TGFbeta and tumor necrosis factor (TNF) pathways and alterations in cell death-related pathways. These may in part explain the idiosyncratic responses of mesenchymal cells to TGFbeta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15344598

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

Review 1.  D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature.

Authors:  C U Manzini; M Sebastiani; D Giuggioli; A Manfredi; M Colaci; A M Cesinaro; C Ferri
Journal:  Clin Rheumatol       Date:  2011-10-12       Impact factor: 2.980

2.  A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis.

Authors:  G Farina; D Lafyatis; R Lemaire; R Lafyatis
Journal:  Arthritis Rheum       Date:  2010-02

Review 3.  COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression.

Authors:  Fernando Vázquez-Villa; Marcos García-Ocaña; José A Galván; Jorge García-Martínez; Carmen García-Pravia; Primitiva Menéndez-Rodríguez; Carmen González-del Rey; Luis Barneo-Serra; Juan R de Los Toyos
Journal:  Tumour Biol       Date:  2015-03-12

Review 4.  Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy.

Authors:  Richard Barrett; Ellen Puré
Journal:  Curr Opin Immunol       Date:  2020-05-11       Impact factor: 7.486

Review 5.  Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy.

Authors:  Richard Lee Barrett; Ellen Puré
Journal:  Elife       Date:  2020-12-28       Impact factor: 8.140

Review 6.  Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance.

Authors:  Xiaoting Zhou; Yanghong Ni; Xiao Liang; Yi Lin; Biao An; Xiang He; Xia Zhao
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

7.  Influence of TGFBR2, TGFB3, DNMT1, and DNMT3A Knockdowns on CTGF, TGFBR2, and DNMT3A in Neonatal and Adult Human Dermal Fibroblasts Cell Lines.

Authors:  Katarzyna Tomela; Justyna A Karolak; Barbara Ginter-Matuszewska; Michal Kabza; Marzena Gajecka
Journal:  Curr Issues Mol Biol       Date:  2021-06-03       Impact factor: 2.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.